organophosphonates has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, WM; Andrade-Gordon, P; de Garavilla, L; Greco, MN; Haertlein, BJ; Maryanoff, BE; Wells, GI | 1 |
| Andrade-Gordon, P; Chen, ZW; Corcoran, TW; Damiano, BP; de Garavilla, L; Derian, CK; Di Cera, E; Eckardt, AJ; Giardino, EC; Greco, MN; Haertlein, BJ; Kauffman, JA; Maryanoff, BE; Mathews, FS; Pineda, AO; Sukumar, N; Wells, GI | 1 |
2 other study(ies) available for organophosphonates and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Dual inhibition of cathepsin G and chymase is effective in animal models of pulmonary inflammation.
Topics: Animals; Biomarkers; Bronchoalveolar Lavage Fluid; Cathepsin G; Chymases; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Injections, Intravenous; Lung Diseases; Mice; Organophosphonates; Piperidines; Pulmonary Disease, Chronic Obstructive; Rats; Sheep; Treatment Outcome | 2010 |
A novel, potent dual inhibitor of the leukocyte proteases cathepsin G and chymase: molecular mechanisms and anti-inflammatory activity in vivo.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cathepsin G; Cathepsins; Chymases; Crystallography, X-Ray; Humans; Leukocytes; Male; Mast Cells; Organophosphonates; Peritonitis; Piperidines; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; Serine Endopeptidases; Serine Proteinase Inhibitors | 2005 |